Deutsche Bank Raises BrightSpring Health Services (BTSG) PT to $30 Following Strong Q2 Growth

BrightSpring Health Services Inc. (NASDAQ:BTSG) is one of the best IPO stocks to buy and hold for 3 years. On September 9, Deutsche Bank analyst Pito Chickering raised the firm’s price target on BrightSpring Health to $30 from $25, while maintaining a Buy rating on the shares.

Earlier in August, BrightSpring Health Services also released its Q2 2025 earnings, where the company’s total revenue grew by 29% year-over-year to $3.1 billion, primarily due to its Pharmacy Solutions segment. This segment in particular saw a 32% increase in revenue and reached $2.8 billion. Within Pharmacy Solutions, infusion and specialty revenue surged by 39% to $2.2 billion, and specialty scripts grew by 38%.

Deutsche Bank Raises BrightSpring Health Services (BTSG) PT to $30 Following Strong Q2 Growth

15 States with the Best Healthcare in the US

The Provider Services segment also contributed to the growth with an 11% increase in revenue to $358 million. This segment’s growth was fueled by home healthcare revenue, which rose 17% to $185 million, along with increases in rehab revenue by 9% to $73 million and personal care revenue by 4% to $100 million. Overall, the company’s gross profit increased by 20% year-over-year to $375 million.

BrightSpring Health Services Inc. is a home and community-based healthcare services platform in the US. It has 2 segments: Pharmacy Solutions and Provider Services.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

This article is originally published at Insider Monkey.